| Literature DB >> 34496239 |
Gladiola Goranci-Buzhala1, Aruljothi Mariappan1, Lucia Ricci-Vitiani2, Natasa Josipovic3, Simone Pacioni4, Marco Gottardo1, Johannes Ptok5, Heiner Schaal5, Giuliano Callaini6, Krishnaraj Rajalingam7, Brian Dynlacht8, Kamyar Hadian9, Argyris Papantonis3, Roberto Pallini4, Jay Gopalakrishnan10.
Abstract
Glioblastoma multiforme (GBM) possesses glioma stem cells (GSCs) that promote self-renewal, tumor propagation, and relapse. Understanding the mechanisms of GSCs self-renewal can offer targeted therapeutic interventions. However, insufficient knowledge of GSCs' fundamental biology is a significant bottleneck hindering these efforts. Here, we show that patient-derived GSCs recruit elevated levels of proteins that ensure the temporal cilium disassembly, leading to suppressed ciliogenesis. Depleting the cilia disassembly complex components is sufficient to induce ciliogenesis in a subset of GSCs via relocating platelet-derived growth factor receptor-alpha (PDGFR-α) to a newly induced cilium. Importantly, restoring ciliogenesis enabled GSCs to switch from self-renewal to differentiation. Finally, using an organoid-based glioma invasion assay and brain xenografts in mice, we establish that ciliogenesis-induced differentiation can prevent the infiltration of GSCs into the brain. Our findings illustrate a role for cilium as a molecular switch in determining GSCs' fate and suggest cilium induction as an attractive strategy to intervene in GSCs proliferation.Entities:
Keywords: brain organoids; cell cycle; cilium checkpoint; confocal 3D imaging; glioblastoma; invasion assay; primary cilium; tissue clearing
Mesh:
Year: 2021 PMID: 34496239 DOI: 10.1016/j.celrep.2021.109656
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423